HR-1703-119
Placed on the Union Calendar, Calendar No. 656.
Sponsored by John Joyce (R-PA)
What it does
This bill would require the Centers for Medicare & Medicaid Services (CMS) to create at least two separate billing codes for ultralightweight manual wheelchairs under Medicare — one for wheelchairs made with titanium or carbon fiber, and one for those made with other materials. Medicare payment rates for suppliers would remain the same as under current rules, but suppliers would be allowed to charge beneficiaries the difference between the Medicare payment and the actual cost of the wheelchair. CMS would also have the option to require suppliers to notify beneficiaries of any out-of-pocket costs they may owe before purchase.
Who benefits
Medicare beneficiaries who want or need ultralightweight titanium or carbon fiber wheelchairs would gain a formal pathway to obtain them through Medicare, even if at additional personal cost. Wheelchair suppliers and manufacturers of premium materials (titanium, carbon fiber) would benefit from a clearer billing structure and the ability to recoup costs above Medicare's payment rate. Occupational and physical therapists whose patients need these chairs may find it easier to prescribe them. Indirectly, wheelchair manufacturers specializing in high-performance or lightweight models could see increased demand.
Who is hurt
Medicare beneficiaries with limited incomes who cannot afford the cost difference between Medicare's payment rate and the actual price of a titanium or carbon fiber wheelchair may be unable to access these models despite the new billing pathway. Beneficiaries on fixed incomes could face unexpected out-of-pocket liability if disclosure requirements are inadequate. Suppliers of standard (non-titanium, non-carbon fiber) wheelchairs may face competitive pressure. Taxpayers and the Medicare program could face modest administrative costs associated with implementing the new billing codes.
Supporters argue
Supporters argue that ultralightweight titanium and carbon fiber wheelchairs provide measurable clinical benefits — including reduced shoulder injury risk and improved long-term mobility — for users who depend on manual wheelchairs full-time, yet Medicare's current billing structure does not distinguish between premium and standard materials. They contend that creating separate billing codes gives beneficiaries a meaningful choice and allows suppliers to offer higher-quality equipment without absorbing the cost difference, expanding access to clinically superior options that the current system effectively blocks.
Opponents argue
Opponents argue that allowing suppliers to bill beneficiaries for the cost difference above Medicare's payment rate could expose low-income and fixed-income seniors to significant and unpredictable out-of-pocket expenses for medically necessary equipment. They contend that without a robust mandatory disclosure requirement — the bill only gives CMS the option to require notification — beneficiaries may agree to purchases without fully understanding their financial liability, replicating the same balance-billing concerns that have historically harmed vulnerable Medicare populations.